search
Back to results

A Rapid Diagnostic of Risk in Hospitalized Patients Using Machine Learning

Primary Purpose

Sepsis, Septicemia, Respiratory Failure

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
eCARTv5 clinical deterioration monitoring
Standard of care control
Sponsored by
AgileMD, Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Sepsis focused on measuring machine learning, artificial intelligence, early warning scores, clinical decision support

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: 18 years old Admitted to an eCART-monitored medical-surgical unit (scoring location) Exclusion Criteria: Younger than 18 years old Not admitted to an eCART-monitored medical surgical unit (scoring location)

Sites / Locations

  • BayCare Health SystemRecruiting
  • University of Wisconsin HealthRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Intervention Arm

Control Arm

Arm Description

Intervention Arm (experimental): eCARTv5 will monitor all adult medical-surgical (ward) patients at hospitals that implement the tool in their EHR. A pre vs. post analysis will be done to compare the impact of the tool at the intervention hospitals.

Control Arm (active comparator): hospital sites that do not implement eCARTv5 will be active comparator.

Outcomes

Primary Outcome Measures

Hospital mortality for elevated risk patients
Hospital mortality, a measure of how many patients died in the hospital, will come from administrative data, specifically from the discharge disposition of each eCART elevated risk patient. This data will be taken from the complete hospitalization, from admission to discharge.

Secondary Outcome Measures

Total hospital length of stay (LOS) for elevated risk patients
Total hospital length of stay (LOS) for patients with any elevated eCART score during hospitalization, defined as the time period between hospital admission and discharge. LOS is defined as the time (hours or fraction of a day) from first vital sign to last vital sign within a patient encounter.
ICU-free days following an eCART elevation
30-day ICU-free days, defined as the number of days patients were both alive and not being cared for in an ICU in the first 30 days following hospital admission with any elevated eCART score. Because death is biased toward fewer ICU days and is a competing outcome, patients who die prior to day 30 are assigned with 0 ICU-free days.
Ventilator-free days following an eCART elevation
30-day ventilator-free days, defined as the number of days patients were both alive and not mechanically ventilated in the first 30 days following hospital admission with any elevated eCART score. Because death is biased toward fewer ventilator days and is a competing outcome, patients who die prior to day 30 are assigned with 0 ventilator-free days.

Full Information

First Posted
April 24, 2023
Last Updated
June 6, 2023
Sponsor
AgileMD, Inc.
Collaborators
Department of Health and Human Services, University of Chicago, BayCare Health System, University of Wisconsin, Madison
search

1. Study Identification

Unique Protocol Identification Number
NCT05893420
Brief Title
A Rapid Diagnostic of Risk in Hospitalized Patients Using Machine Learning
Official Title
A Rapid Diagnostic of Risk in Hospitalized Patients With COVID-19, Sepsis, and Other High-Risk Conditions to Improve Outcomes and Critical Resource Allocation Using Machine Learning
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Recruiting
Study Start Date
December 1, 2022 (Actual)
Primary Completion Date
December 31, 2023 (Anticipated)
Study Completion Date
June 30, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
AgileMD, Inc.
Collaborators
Department of Health and Human Services, University of Chicago, BayCare Health System, University of Wisconsin, Madison

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Device Product Not Approved or Cleared by U.S. FDA
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
In this study, the investigators will deploy a software-based clinical decision support tool (eCARTv5) into the electronic health record (EHR) workflow of multiple hospital wards. eCART's algorithm is designed to analyze real-time EHR data, such as vitals and laboratory results, to identify which patients are at increased risk for clinical deterioration. The algorithm specifically predicts imminent death or the need for intensive care unit (ICU) transfer. Within the eCART interface, clinical teams are then directed toward standardized guidance to determine next steps in care for elevated-risk patients. The investigators hypothesize that implementing such a tool will be associated with a decrease in ventilator utilization, length of stay, and mortality for high-risk hospitalized adults.
Detailed Description
The objective of this proposal is to rapidly deploy a clinical decision support tool (eCARTv5) within the electronic health record of multiple medical-surgical units. eCART combines a real-time machine learning algorithm for identifying patients at increased risk for intensive care (ICU) transfer and death with clinical pathways to standardize the care of these patients based on a real-time, quantitative assessment of patient risk. The investigators hypothesize that implementing such a tool will be associated with a decrease in ventilator utilization, length of stay, and mortality for high-risk hospitalized adults. Background: Clinical deterioration occurs in approximately 5% of hospitalized adults. Delays in recognition of deterioration heighten the risk of adverse outcomes. Machine learning algorithms enhance clinical decision-making and can improve the quality of patient care. However, their impact on clinical outcomes depends not only on the sensitivity and specificity of the algorithm but also on how well that algorithm is integrated into provider workflows and facilitates timely and appropriate intervention. Preliminary Data: eCART has been built upon more than a decade of ongoing scientific research and chronicled in numerous peer-reviewed publications. eCART was developed at the University of Chicago by Drs. Dana Edelson and Matthew Churpek. The first version (eCARTv1) was derived and validated using linear logistic regression in a dataset of nearly 60,000 adult ward patients from a single medical center. That model had 16 variables in it and was subsequently validated in silent mode, demonstrating that eCART could alert clinicians more than 24 hours in advance of ICU transfer or cardiac arrest. eCARTv2, derived and validated in a dataset of nearly 270,000 patients from 5 hospitals, improved upon the earlier version by utilizing a cubic spline logistic regression model with 27 variables and demonstrated improved accuracy over the Modified Early Warning Score (MEWS), a commonly used score that can be hand- calculated by nurses at the bedside (AUC 0.77 vs. 0.70 for cardiac arrest, ICU transfer or death). In a multicenter clinical implementation study, eCARTv2 was associated with a 29% relative risk reduction for mortality. In further development of eCART, the University of Chicago research team demonstrated that upgrading from a cubic spline model to a machine learning model, such as a random forest or gradient boosted machine (GBM), could increase the AUC. In the most recent development - eCART v5 - the research team has advanced the analytic using a gradient boosted machine learning model trained on a multi-center dataset of more than 800,000 patient records. Now with 97 variables, this more sophisticated model increases the accuracy by which clinicians can predict clinical deterioration.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sepsis, Septicemia, Respiratory Failure, Hemodynamic Instability, COVID-19, Cardiac Arrest, Clinical Deterioration
Keywords
machine learning, artificial intelligence, early warning scores, clinical decision support

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
This a parallel study with an intervention group of medical-surgical patients where the tool will be used by providers, and a control group wherein the tool will run silently in the background. The primary analysis will utilize a delta-delta design comparing the intervention hospitals' pre vs. post results to the control hospitals' pre vs. post results. The primary analysis will be limited to patients who ever had an elevated eCARTv5 as those are the ones who would have been eligible for intervention (viewing of the eCARTv5 trend and following the clinical pathway).
Masking
ParticipantCare ProviderOutcomes Assessor
Masking Description
In control hospitals, eCART will be scoring silently in the background and not visible to the care provider or the patient. Because this is administrative data, the outcomes assessor will similarly be blinded to the score. In the intervention hospitals, care providers will be aware of the score and trained to it. Patients may be aware as a result.
Allocation
Non-Randomized
Enrollment
30000 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intervention Arm
Arm Type
Experimental
Arm Description
Intervention Arm (experimental): eCARTv5 will monitor all adult medical-surgical (ward) patients at hospitals that implement the tool in their EHR. A pre vs. post analysis will be done to compare the impact of the tool at the intervention hospitals.
Arm Title
Control Arm
Arm Type
Active Comparator
Arm Description
Control Arm (active comparator): hospital sites that do not implement eCARTv5 will be active comparator.
Intervention Type
Device
Intervention Name(s)
eCARTv5 clinical deterioration monitoring
Intervention Description
eCART is a predictive analytic used for the identification of acute clinical deterioration built upon more than a decade of ongoing scientific research and chronicled in numerous peer-reviewed publications. eCART draws upon readily available patient data from the EHR, rapidly quantifies disease severity, and predicts the likelihood of critical illness onset.
Intervention Type
Other
Intervention Name(s)
Standard of care control
Intervention Description
Standard of care is the health system's clinical best practices and workflows for identifying high-risk patients for clinical deterioration, including other tools already built into the electronic health record (EHR). Hospitals that do not implement eCARTv5 will be compared as a control against hospitals that do implement eCARTv5.
Primary Outcome Measure Information:
Title
Hospital mortality for elevated risk patients
Description
Hospital mortality, a measure of how many patients died in the hospital, will come from administrative data, specifically from the discharge disposition of each eCART elevated risk patient. This data will be taken from the complete hospitalization, from admission to discharge.
Time Frame
The outcome of hospital mortality for elevated risk patients will be tracked across 12 months
Secondary Outcome Measure Information:
Title
Total hospital length of stay (LOS) for elevated risk patients
Description
Total hospital length of stay (LOS) for patients with any elevated eCART score during hospitalization, defined as the time period between hospital admission and discharge. LOS is defined as the time (hours or fraction of a day) from first vital sign to last vital sign within a patient encounter.
Time Frame
Total hospital length of stay (LOS) for elevated risk patients will be tracked across 12 months
Title
ICU-free days following an eCART elevation
Description
30-day ICU-free days, defined as the number of days patients were both alive and not being cared for in an ICU in the first 30 days following hospital admission with any elevated eCART score. Because death is biased toward fewer ICU days and is a competing outcome, patients who die prior to day 30 are assigned with 0 ICU-free days.
Time Frame
The outcome of 30-day ICU-free days will be tracked across 12 months
Title
Ventilator-free days following an eCART elevation
Description
30-day ventilator-free days, defined as the number of days patients were both alive and not mechanically ventilated in the first 30 days following hospital admission with any elevated eCART score. Because death is biased toward fewer ventilator days and is a competing outcome, patients who die prior to day 30 are assigned with 0 ventilator-free days.
Time Frame
The outcome of 30-day ventilator-free days will be tracked across 12 months
Other Pre-specified Outcome Measures:
Title
Sepsis Mortality
Description
Hospital mortality, a measure of how many patients died in the hospital, will come from administrative data, specifically from the discharge disposition of each eCART elevated risk patient meeting Sep-1 criteria for sepsis.
Time Frame
The outcome of sepsis mortality will be tracked across 12 months
Title
Sepsis Length of Stay (LOS)
Description
Total hospital length of stay (LOS) for patients with any elevated eCART score during hospitalization that met Sep-1 criteria for sepsis.
Time Frame
The outcome of sepsis length of stay (LOS) will be tracked across 12 months
Title
COVID-19 Mortality
Description
Hospital mortality, a measure of how many patients died in the hospital, will come from administrative data, specifically from the discharge disposition of each eCART elevated risk patient with a COVID-19 diagnosis or positive COVID-19 test result.
Time Frame
The outcome of COVID-19 mortality will be tracked across 12 months
Title
COVID-19 Length of Stay (LOS)
Description
Total hospital length of stay (LOS) for patients with any elevated eCART score during hospitalization with a COVID-19 diagnosis or positive COVID-19 test result.
Time Frame
The outcomes of COVID-19 length of stay (LOS) will be tracked across 12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 18 years old Admitted to an eCART-monitored medical-surgical unit (scoring location) Exclusion Criteria: Younger than 18 years old Not admitted to an eCART-monitored medical surgical unit (scoring location)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Dana P Edelson, MD, MS
Phone
415-650-0522
Email
dana@agilemd.com
First Name & Middle Initial & Last Name or Official Title & Degree
Borna Safabakhsh, MS, MBA
Phone
415-650-0522
Email
borna@agilemd.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Dana P Edelson, MD, MS
Organizational Affiliation
AgileMD, Inc.
Official's Role
Study Chair
Facility Information:
Facility Name
BayCare Health System
City
Clearwater
State/Province
Florida
ZIP/Postal Code
33759
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Danielle Mauck, MPH
Phone
727-519-1904
Email
Danielle.mauck@baycare.org
First Name & Middle Initial & Last Name & Degree
Stephanie Yapchanyk, RN, BSN
Phone
813- 533-1416
Email
Stephenie.yapchanyk@baycare.org
First Name & Middle Initial & Last Name & Degree
Devendra N Amin, MBBS
Facility Name
University of Wisconsin Health
City
Madison
State/Province
Wisconsin
ZIP/Postal Code
53792
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Majid Afshar, MD, MS
Phone
608-263-0661
Email
majid.afshar@wisc.edu
First Name & Middle Initial & Last Name & Degree
Majid Afshar, MD, MS

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
22584764
Citation
Churpek MM, Yuen TC, Park SY, Meltzer DO, Hall JB, Edelson DP. Derivation of a cardiac arrest prediction model using ward vital signs*. Crit Care Med. 2012 Jul;40(7):2102-8. doi: 10.1097/CCM.0b013e318250aa5a.
Results Reference
background
PubMed Identifier
25089847
Citation
Churpek MM, Yuen TC, Winslow C, Robicsek AA, Meltzer DO, Gibbons RD, Edelson DP. Multicenter development and validation of a risk stratification tool for ward patients. Am J Respir Crit Care Med. 2014 Sep 15;190(6):649-55. doi: 10.1164/rccm.201406-1022OC.
Results Reference
background
PubMed Identifier
27075140
Citation
Kang MA, Churpek MM, Zadravecz FJ, Adhikari R, Twu NM, Edelson DP. Real-Time Risk Prediction on the Wards: A Feasibility Study. Crit Care Med. 2016 Aug;44(8):1468-73. doi: 10.1097/CCM.0000000000001716.
Results Reference
background
PubMed Identifier
35452010
Citation
Winslow CJ, Edelson DP, Churpek MM, Taneja M, Shah NS, Datta A, Wang CH, Ravichandran U, McNulty P, Kharasch M, Halasyamani LK. The Impact of a Machine Learning Early Warning Score on Hospital Mortality: A Multicenter Clinical Intervention Trial. Crit Care Med. 2022 Sep 1;50(9):1339-1347. doi: 10.1097/CCM.0000000000005492. Epub 2022 Aug 15.
Results Reference
background

Learn more about this trial

A Rapid Diagnostic of Risk in Hospitalized Patients Using Machine Learning

We'll reach out to this number within 24 hrs